Stock Market Today, Nov. 3: Palantir Falls After Q3 Results as Valuation Stays in Focus

Palantir shares fell 1.65% to $175.40 on Nov. 3, with trading volume 66% above its three-month average, as investors focused on future growth despite strong Q3 results. Revenue exceeded $2 billion for the first time, and the company raised 2026 sales guidance to $8.53 billion; U.S. commercial revenue surged 148% year over year to $984 million. However, RPO was unchanged at $4.9 billion from Q2 and TCV growth slowed to 11% year over year from 153% in Q2, while the stock traded at about 86 times forward earnings.

Analysis

The key issue is not one flat backlog reading; it is whether new deal formation is keeping pace with the revenue base implied by elevated growth expectations. RPO can be lumpy and duration-sensitive, while lifetime TCV may include deals with different timing and conversion certainty. Treat the divergence as a warning signal, not proof that demand has stalled. The near-term asymmetry is valuation: if bookings fail to reaccelerate, even solid revenue delivery may not protect the multiple; if U.S. commercial demand converts into durable, repeatable contracts, the current concern could fade quickly.

Over the next 1–3 months, focus on the next bookings/RPO update, commercial customer additions and expansion, and whether guidance is supported by recognized revenue rather than large potential contract values. Over 6–18 months, execution capacity and the economics of deployment matter: rapid customer wins create value only if implementation scales without absorbing the gains in delivery costs. Large software platforms and specialist analytics vendors could compete for enterprise budgets, but the relevant threat is substitution in specific workflows, not a simple category-wide displacement.

Contrarian read: the market may be over-weighting two noisy contract metrics immediately after strong reported demand; equally, reported revenue strength may be lagging evidence while forward commitments cool. The high-volume, market-relative decline raises the bar for a quick recovery, but does not establish capitulation. Verify contract duration, cancellations, conversion rates, and the contribution of large deals before treating either interpretation as confirmed.

Key Decisions for Investors

• Avoid adding to PLTR solely on the pullback. For existing exposure, consider a temporary hedge or trim if the position is sized for continued premium-multiple growth; do not initiate an outright short until the next update confirms weaker bookings or guidance.
• Set a 1–3 month evidence test: look for sequential improvement in RPO or credible acceleration in commercial bookings, alongside conversion of contracted demand into revenue. A further slowdown, especially with weaker guidance, would strengthen the downside case; stable bookings and sustained commercial expansion would falsify it.
• If hedging with options, first compare put-spread cost with implied volatility after the earnings reaction; avoid paying for protection if event volatility remains unusually expensive. No strikes or payoff estimate are supportable without the option surface and position horizon.
• Before making a directional call, verify RPO duration and composition, TCV-to-RPO conversion, cancellation terms, and whether commercial growth is broad-based or driven by a few large contracts. These details determine whether the headline metrics signal timing noise or a genuine demand inflection.